USPTO serial 98058715
METEOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWEENEY, MOLLY B
- Law office
- TMO LAW OFFICE 121
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with METEOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. TROUTMAN PEPPER HAMILTON SANDERS LLP875 THIRD AVENUEC/O IP SERVICES NYCNEW YORK, NY 10022Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical and biological precursors for scientific purposes in relation to antibodies and multi-specific antibodies; biochemical and biological precursors for scientific purposes in relation to gamma delta t cells; biochemical and biological precursors for scientific purposes in relation to immunohistochemistry (IHC) and flow cytometry; Biochemical and biological preparations for scientific and research purposes | ACTIVE | — |
| 005 | Medical, biochemical, biological, and pharmaceutical preparations for use in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, haematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, urological diseases and disorders, viral diseases and disorders, rare diseases, namely, autoimmune rare diseases, bacterial infectious rare diseases, cardiological rare diseases, central and peripheral nervous systems rare diseases, diabetes rare diseases, endocrinological rare diseases, haematological rare diseases, hormonally originating rare diseases, gastroenterological rare diseases, gout rare diseases, infectious rare diseases, inflammatory rare diseases, musculoskeletal rare diseases, genetic rare diseases, neurological rare diseases, oncological cancer rare diseases, respiratory rare diseases, urological and kidney rare diseases, viral rare diseases for medical and pharmaceutical use | ACTIVE | — |
| 041 | Education services, namely, arranging and conducting classes, courses, seminars, conferences, congresses, symposiums, trainings and workshops in the fields of medicine, biochemical and biological materials and pharmaceuticals | ACTIVE | — |
| 042 | Medical and scientific research and development services in the field of pharmaceutical products, biochemical and biological preparations; design, engineering, research, development, consultation and testing services in the field of pharmaceuticals, biochemical and biological preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GammaDelta Therapeutics Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named METEOR
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 5, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2025 | ALIE | ASSIGNED TO LIE | — |
| Apr 10, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 7, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 2, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 2, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 2, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 19, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 19, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 19, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 19, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 19, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2023 | NWAP | NEW APPLICATION ENTERED | — |